Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy-Reference-Cited by-同舟云学术

Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy

Published:2023-12-16 Issue: Volume: Page:
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Udagawa Shohei,Osumi Hiroki,Kozuki Ryotaro,Ooki Akira,Wakatsuki Takeru,Kurihara Nozomi,Mukai Toshiki,Yamaguchi Tomohiro,Akiyoshi Takashi,Fukunaga Yosuke,Yamaguchi Kensei,Shinozaki Eiji

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00595-023-02779-6.pdf

Reference38 articles.

1. World Health Organization. Cancer today. 2020. https://gco.iarc.fr/today/home. Accessed 24 May 2023.

2. Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, et al. Duration of adjuvant chemotherapy for Stage III colon cancer. N Engl J Med. 2018;378:1177–88.

3. Yoshino T, Argilés G, Oki E, Martinelli E, Taniguchi H, Arnold D, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol. 2021;32:1496–510.

4. Cohen R, Taieb J, Fiskum J, Yothers G, Goldberg R, Yoshino T, et al. Microsatellite instability in patients with Stage III colon cancer receiving fluoropyrimidine with or without oxaliplatin: an accent pooled analysis of 12 adjuvant trials. J Clin Oncol. 2021;39:642–51.

5. Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31:4465–70.